{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:57:07Z","timestamp":1780451827557,"version":"3.54.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH307andZR2021MH306"],"award-info":[{"award-number":["ZR2023MH307andZR2021MH306"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH307andZR2021MH306"],"award-info":[{"award-number":["ZR2023MH307andZR2021MH306"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81770915 and 81301737"],"award-info":[{"award-number":["81770915 and 81301737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11302-025-10108-4","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T03:51:22Z","timestamp":1755834682000},"page":"1249-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The P2X7 receptor in leukemia: pathological mechanisms and therapeutic potential"],"prefix":"10.1007","volume":"21","author":[{"given":"Yanwen","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-2563","authenticated-orcid":false,"given":"Ronglan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"10108_CR1","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","volume":"18","author":"D Rodriguez-Abreu","year":"2007","unstructured":"Rodriguez-Abreu D, Bordoni A, Zucca E (2007) Epidemiology of hematological malignancies. Ann Oncol 18 Suppl 1:i3\u2013i8. https:\/\/doi.org\/10.1093\/annonc\/mdl443","journal-title":"Ann Oncol"},{"key":"10108_CR2","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"10108_CR3","doi-asserted-by":"publisher","unstructured":"Bispo JAB, Pinheiro PS, Kobetz EK (2020) Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med 10(6):a034819. https:\/\/doi.org\/10.1101\/cshperspect.a034819","DOI":"10.1101\/cshperspect.a034819"},{"issue":"1","key":"10108_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16226-1","volume":"23","author":"K Lin","year":"2023","unstructured":"Lin K, Jia H, Cao M, Xu T, Chen Z, Song X et al (2023) Epidemiological characteristics of leukemia in China, 2005\u20132017: a log-linear regression and age-period-cohort analysis. BMC Public Health 23(1):1647. https:\/\/doi.org\/10.1186\/s12889-023-16226-1","journal-title":"BMC Public Health"},{"issue":"3","key":"10108_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_438662","volume":"44","author":"Y Abaza","year":"2024","unstructured":"Abaza Y, McMahon C, Garcia JS (2024) Advancements and challenges in the treatment of AML. Am Soc Clin Oncol Educ Book 44(3):e438662. https:\/\/doi.org\/10.1200\/edbk_438662","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"11","key":"10108_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112496","volume":"9","author":"V Vultaggio-Poma","year":"2020","unstructured":"Vultaggio-Poma V, Sarti AC, Di Virgilio F (2020) Extracellular ATP: a feasible target for cancer therapy. Cells 9(11):2496. https:\/\/doi.org\/10.3390\/cells9112496","journal-title":"Cells"},{"key":"10108_CR7","doi-asserted-by":"publisher","unstructured":"Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64(12):1471\u20131483. https:\/\/doi.org\/10.1007\/s00018-007-6497-0","DOI":"10.1007\/s00018-007-6497-0"},{"key":"10108_CR8","doi-asserted-by":"publisher","unstructured":"Sluyter R (2017) The P2X7 receptor. Adv Exp Med Biol 1051:17\u201353. https:\/\/doi.org\/10.1007\/5584_2017_59","DOI":"10.1007\/5584_2017_59"},{"key":"10108_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1297775","volume":"13","author":"GP Zhang","year":"2024","unstructured":"Zhang GP, Liao JX, Liu YY, Zhu FQ, Huang HJ, Zhang WJ (2024) Ion channel P2X7 receptor in the progression of cancer. Front Oncol 13:1297775. https:\/\/doi.org\/10.3389\/fonc.2023.1297775","journal-title":"Front Oncol"},{"key":"10108_CR10","doi-asserted-by":"publisher","unstructured":"De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A et al (2019) The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene 38(19):3636\u20133650. https:\/\/doi.org\/10.1038\/s41388-019-0684-y","DOI":"10.1038\/s41388-019-0684-y"},{"key":"10108_CR11","doi-asserted-by":"publisher","first-page":"645605","DOI":"10.3389\/fcell.2021.645605","volume":"9","author":"E De Marchi","year":"2021","unstructured":"De Marchi E, Pegoraro A, Adinolfi E (2021) P2X7 receptor in hematological malignancies. Front Cell Dev Biol 9:645605. https:\/\/doi.org\/10.3389\/fcell.2021.645605","journal-title":"Front Cell Dev Biol"},{"key":"10108_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fphar.2019.00435","volume":"10","author":"F Furini","year":"2019","unstructured":"Furini F, Giuliani AL, Parlati ME, Govoni M, Di Virgilio F, Bortoluzzi A (2019) P2X7 receptor expression in patients with serositis related to systemic lupus erythematosus. Front Pharmacol 10:435. https:\/\/doi.org\/10.3389\/fphar.2019.00435","journal-title":"Front Pharmacol"},{"key":"10108_CR13","doi-asserted-by":"publisher","unstructured":"Pegoraro A, Adinolfi E (2021) The ATP\/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia. Purinergic Signal 17(3):319\u2013321. https:\/\/doi.org\/10.1007\/s11302-021-09789-4","DOI":"10.1007\/s11302-021-09789-4"},{"key":"10108_CR14","first-page":"347","volume":"56","author":"GN Buell","year":"1998","unstructured":"Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, Antonarakis SE (1998) Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 5(6):347\u2013354","journal-title":"Receptors Channels"},{"key":"10108_CR15","doi-asserted-by":"publisher","unstructured":"Di Virgilio F, Jiang LH, Roger S et al (2019) Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells. Methods Enzymol 629:115\u2013150. https:\/\/doi.org\/10.1016\/bs.mie.2019.07.043","DOI":"10.1016\/bs.mie.2019.07.043"},{"key":"10108_CR16","doi-asserted-by":"publisher","unstructured":"Roger S, Jelassi B, Couillin I, Pelegrin P, Besson P, Jiang LH (2015) Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives. Biochim Biophys Acta 1848(10 Pt B):2584\u20132602. https:\/\/doi.org\/10.1016\/j.bbamem.2014.10.029","DOI":"10.1016\/j.bbamem.2014.10.029"},{"key":"10108_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11302-011-9215-1","volume":"71","author":"HM Costa-Junior","year":"2011","unstructured":"Costa-Junior HM, Sarmento Vieira F, Coutinho-Silva R (2011) C terminus of the P2X7 receptor: treasure hunting. Purinergic Signal 7(1):7\u201319. https:\/\/doi.org\/10.1007\/s11302-011-9215-1","journal-title":"Purinergic Signalling"},{"key":"10108_CR18","doi-asserted-by":"publisher","unstructured":"Liang X, Samways DSK, Cox J, Egan TM (2019) Ca2+ flux through splice variants of the ATP-gated ionotropic receptor P2X7 is regulated by its cytoplasmic N terminus. J Biol Chem 294(33):12521\u201312533. https:\/\/doi.org\/10.1074\/jbc.RA119.009666","DOI":"10.1074\/jbc.RA119.009666"},{"key":"10108_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.149213","volume":"688","author":"K Migita","year":"2023","unstructured":"Migita K, Oyabu K, Terada K (2023) Rectification of ATP-gated current of rat P2X2 and P2X7 receptors depends on the cytoplasmic N-terminus. Biochem Biophys Res Commun 688:149213. https:\/\/doi.org\/10.1016\/j.bbrc.2023.149213","journal-title":"Biochem Biophys Res Commun"},{"key":"10108_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/187221511794839219","volume":"51","author":"R Sluyter","year":"2011","unstructured":"Sluyter R, Stokes L (2011) Significance of P2X7 receptor variants to human health and disease. Recent Pat DNA Gene Seq 5(1):41\u201354. https:\/\/doi.org\/10.2174\/187221511794839219","journal-title":"Recent Pat DNA Gene Seq"},{"key":"10108_CR21","doi-asserted-by":"publisher","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47(1):15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","DOI":"10.1016\/j.immuni.2017.06.020"},{"key":"10108_CR22","doi-asserted-by":"publisher","unstructured":"Wiley JS, Sluyter R, Gu BJ, Stokes L, Fuller SJ (2011) The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78(5):321\u2013332. https:\/\/doi.org\/10.1111\/j.1399-0039.2011.01780.x","DOI":"10.1111\/j.1399-0039.2011.01780.x"},{"issue":"5262","key":"10108_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.272.5262.735","volume":"272","author":"A Surprenant","year":"1996","unstructured":"Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272(5262):735\u2013738. https:\/\/doi.org\/10.1126\/science.272.5262.735","journal-title":"Science (New York, NY)"},{"issue":"12","key":"10108_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.leukres.2004.04.001","volume":"28","author":"X-J Zhang","year":"2004","unstructured":"Zhang XJ, Zheng GG, Ma XT et al (2004) Expression of P2X7 in human hematopoietic cell lines and leukemia patients.\u00a0Leuk Res 28(12):1313\u20131322.\u00a0https:\/\/doi.org\/10.1016\/j.leukres.2004.04.001","journal-title":"Leukemia Res"},{"key":"10108_CR25","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2174\/0929867324666170303161659","volume":"2421","author":"E Orioli","year":"2017","unstructured":"Orioli E, De Marchi E, Giuliani AL, Adinolfi E (2017) P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic\/trophic responses. Curr Med Chem 24(21):2261\u20132275.\u00a0https:\/\/doi.org\/10.2174\/0929867324666170303161659","journal-title":"Curr Med Chem"},{"issue":"6","key":"10108_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/1440-1681.13079","volume":"46","author":"C Guerra Martinez","year":"2019","unstructured":"Guerra Martinez C (2019) P2X7 receptor in cardiovascular disease: the heart side. Clin Exp Pharmacol Physiol 46(6):513\u2013526. https:\/\/doi.org\/10.1111\/1440-1681.13079","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10108_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3389\/fphar.2020.00793","volume":"11","author":"R Lara","year":"2020","unstructured":"Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F,\u00a0McNulty S (2020) P2X7 in cancer: from molecular mechanisms to therapeutics. Front Pharmacol 11:793. https:\/\/doi.org\/10.3389\/fphar.2020.00793","journal-title":"Front Pharmacol"},{"issue":"3","key":"10108_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11302-021-09790-x","volume":"17","author":"L-H Jiang","year":"2021","unstructured":"Jiang LH, Caseley EA, Muench SP, Roger S (2021) Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signal 17(3):331\u2013344. https:\/\/doi.org\/10.1007\/s11302-021-09790-x","journal-title":"Purinergic Signal"},{"key":"10108_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brainresbull.2022.07.006","volume":"187","author":"SQ Hu","year":"2022","unstructured":"Hu SQ, Hu JL, Zou FL, Liu JP, Luo HL, Hu DX et al (2022) P2X7 receptor in inflammation and pain. Brain Res Bull 187:199\u2013209. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.07.006","journal-title":"Brain Res Bull"},{"key":"10108_CR30","doi-asserted-by":"publisher","first-page":"1345625","DOI":"10.3389\/fimmu.2024.1345625","volume":"15","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu Q, Zhou S, Luo H, Zhang W (2024) Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases. Front Immunol 15:1345625. https:\/\/doi.org\/10.3389\/fimmu.2024.1345625","journal-title":"Front Immunol"},{"key":"10108_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","volume":"151","author":"E Adinolfi","year":"2018","unstructured":"Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F (2018) The P2X7 receptor: a main player in inflammation. Biochem Pharmacol 151:234\u2013244. https:\/\/doi.org\/10.1016\/j.bcp.2017.12.021","journal-title":"Biochem Pharmacol"},{"key":"10108_CR32","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2174\/0929867330666230403094538","volume":"3111","author":"I Ghafir El Idrissi","year":"2024","unstructured":"El Idrissi IG, Podlewska S, Abate C, Bojarski AJ, Lacivita E, Leopoldo M\u00a0(2024) Structure-activity relationships and therapeutic potential of purinergic P2X7 receptor antagonists. Curr Med Chem 31(11):1361\u20131403. https:\/\/doi.org\/10.2174\/0929867330666230403094538","journal-title":"Curr Med Chem"},{"key":"10108_CR33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fimmu.2017.00862","volume":"8","author":"M Barber\u00e0-Cremades","year":"2017","unstructured":"Barber\u00e0-Cremades M, G\u00f3mez AI, Baroja-Mazo A, Mart\u00ednez-Alarc\u00f3n L, Mart\u00ednez CM, de Torre-Minguela C, Pelegr\u00edn P (2017) P2X7 receptor induces tumor necrosis factor-\u03b1 converting enzyme activation and release to boost TNF-\u03b1 production. Front Immunol 8:862. https:\/\/doi.org\/10.3389\/fimmu.2017.00862","journal-title":"Front Immunol"},{"key":"10108_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149513","volume":"707","author":"Y-t Zou","year":"2024","unstructured":"Zou YT, Li JY, Chai JY, Hu YS, Zhang WJ, Zhang Q (2024) The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression. Biochem Biophys Res Commun 707:149513. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149513","journal-title":"Biochem Biophys Res Commun"},{"key":"10108_CR35","doi-asserted-by":"publisher","first-page":"e0304062","DOI":"10.1371\/journal.pone.0304062","volume":"196","author":"A Mohammed","year":"2024","unstructured":"Nu\u00f1ez-R\u00edos JD, Reyna-Jeldes M, Mata-Mart\u00ednez E, Campos-Contreras ADR, Lazcano-S\u00e1nchez I\u00a0Lazcano-S\u00e1nchez I et al (2024) Extracellular ATP\/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells. PLos One 19(6):e0304062. https:\/\/doi.org\/10.1371\/journal.pone.0304062","journal-title":"Plos One"},{"key":"10108_CR36","doi-asserted-by":"publisher","unstructured":"Janho Dit Hreich S, Hofman P, Vouret-Craviari V (2023) The role of IL-18 in P2RX7-mediated antitumor immunity. Int J Mol Sci 24(11):9235. https:\/\/doi.org\/10.3390\/ijms24119235","DOI":"10.3390\/ijms24119235"},{"issue":"12","key":"10108_CR37","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1158\/0008-5472.Can-11-1947","volume":"72","author":"E Adinolfi","year":"2012","unstructured":"Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P et al (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72(12):2957\u20132969. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-1947","journal-title":"Cancer Res"},{"key":"10108_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2019.02.012","volume":"47","author":"E Adinolfi","year":"2019","unstructured":"Adinolfi E, De Marchi E, Orioli E, Pegoraro A, Di Virgilio F (2019) Role of the P2X7 receptor in tumor-associated inflammation. Curr Opin Pharmacol 47:59\u201364. https:\/\/doi.org\/10.1016\/j.coph.2019.02.012","journal-title":"Curr Opin Pharmacol"},{"key":"10108_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109844","volume":"125","author":"W-j Zhang","year":"2020","unstructured":"Zhang WJ, Hu CG, Zhu ZM, Luo HL (2020) Effect of P2X7 receptor on tumorigenesis and its pharmacological properties. Biomed Pharmacother 125:109844. https:\/\/doi.org\/10.1016\/j.biopha.2020.109844","journal-title":"Biomed Pharmacother"},{"key":"10108_CR40","doi-asserted-by":"publisher","unstructured":"Yang X, Ji Y, Mei L, Jing W, Yang X, Liu Q (2024) Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma. Purinergic Signal 20(3):273\u2013284. https:\/\/doi.org\/10.1007\/s11302-023-09947-w","DOI":"10.1007\/s11302-023-09947-w"},{"key":"10108_CR41","doi-asserted-by":"publisher","unstructured":"Maty\u015bniak D, Chumak V, Nowak N, Kukla A, Lehka L, Oslislok M et al (2022) P2X7 receptor: the regulator of glioma tumor development and survival. Purinergic Signal 18(1):135\u2013154. https:\/\/doi.org\/10.1007\/s11302-021-09834-2","DOI":"10.1007\/s11302-021-09834-2"},{"key":"10108_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12967-023-03985-z","volume":"211","author":"G Sheng","year":"2023","unstructured":"Sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S et al (2023) P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization. J Transl Med 21(1):132. https:\/\/doi.org\/10.1186\/s12967-023-03985-z","journal-title":"J Transl Med"},{"key":"10108_CR43","doi-asserted-by":"publisher","unstructured":"Song H, Arredondo Carrera HM, Sprules A, Ji Y, Zhang T, He J et al (2023) C-terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis \u2013 evidence from clinical and pre-clinical data. Cancer Commun(Lond) 43(3):400\u2013404. https:\/\/doi.org\/10.1002\/cac2.12391","DOI":"10.1002\/cac2.12391"},{"issue":"18","key":"10108_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813906","volume":"24","author":"E Adinolfi","year":"2023","unstructured":"Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A (2023) The P2X7 receptor in oncogenesis and metastatic dissemination: new insights on vesicular release and adenosinergic crosstalk. Int J Mol Sci 24(18):13906. https:\/\/doi.org\/10.3390\/ijms241813906","journal-title":"Int J Mol Sci"},{"key":"10108_CR45","doi-asserted-by":"publisher","first-page":"592442","DOI":"10.3389\/fcell.2020.592442","volume":"8","author":"M Brenet","year":"2021","unstructured":"Brenet M, Mart\u00ednez S, P\u00e9rez-Nu\u00f1ez R, P\u00e9rez LA, Contreras P, D\u00edaz J et al (2021) Thy-1 (CD90)-induced metastatic cancer cell migration and invasion are \u03b23 integrin-dependent and involve a Ca2+\/P2X7 receptor signaling axis. Front Cell Dev Biol 8:592442. https:\/\/doi.org\/10.3389\/fcell.2020.592442","journal-title":"Front Cell Dev Biol"},{"key":"10108_CR46","doi-asserted-by":"publisher","unstructured":"Xia J, Yu X, Tang L, Li G, He T (2015) P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncol Rep 34(1):103\u2013110. https:\/\/doi.org\/10.3892\/or.2015.3979","DOI":"10.3892\/or.2015.3979"},{"key":"10108_CR47","doi-asserted-by":"publisher","unstructured":"Zhang Y, Cheng H, Li W, Wu H, Yang Y (2019) Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS\/MNNG osteosarcoma cells via PI3K\/Akt\/GSK3\u03b2\/\u03b2-catenin and mTOR\/HIF1\u03b1\/VEGF signaling. Int J Cancer 145(4):1068\u20131082. https:\/\/doi.org\/10.1002\/ijc.32207","DOI":"10.1002\/ijc.32207"},{"key":"10108_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41418-022-01095-9","volume":"302","author":"S Missiroli","year":"2022","unstructured":"Missiroli S, Perrone M, Gaf\u00e0 R, Nicoli F, Bonora M, Morciano G et al (2023) PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment. Cell Death Differ 30(2):429\u2013441. https:\/\/doi.org\/10.1038\/s41418-022-01095-9","journal-title":"Cell Death Differ"},{"key":"10108_CR49","doi-asserted-by":"publisher","first-page":"694831","DOI":"10.3389\/fcell.2021.694831","volume":"9","author":"F Grassi","year":"2021","unstructured":"Grassi F, De Ponte Conti B (2021) The P2X7 receptor in tumor immunity. Front Cell Dev Biol 9:694831. https:\/\/doi.org\/10.3389\/fcell.2021.694831","journal-title":"Front Cell Dev Biol"},{"key":"10108_CR50","doi-asserted-by":"publisher","first-page":"e60184","DOI":"10.1371\/journal.pone.0060184","volume":"84","author":"J Kanellopoulos","year":"2013","unstructured":"Bian S, Sun X, Bai A, Zhang C, Li L et al (2013) P2X7 Integrates PI3K\/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One 8(4):e60184. https:\/\/doi.org\/10.1371\/journal.pone.0060184","journal-title":"PLoS ONE"},{"key":"10108_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-023-06408-5","volume":"151","author":"KC-Y Huang","year":"2024","unstructured":"Huang KC, Chiang SF, Lin PC, Hong WZ, Yang PC, Chang HP et al (2024) TNF\u03b1 modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell Death Dis 15(1):24. https:\/\/doi.org\/10.1038\/s41419-023-06408-5","journal-title":"Cell Death Dis"},{"key":"10108_CR52","doi-asserted-by":"publisher","unstructured":"Douguet L, Janho Dit Hreich S, Benzaquen J, Seguin L, Juhel T, Dezitter X et al (2021) A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy. Nat Commun 12(1):653. https:\/\/doi.org\/10.1038\/s41467-021-20912-2","DOI":"10.1038\/s41467-021-20912-2"},{"key":"10108_CR53","doi-asserted-by":"publisher","first-page":"1287310","DOI":"10.3389\/fimmu.2023.1287310","volume":"14","author":"RM Sainz","year":"2023","unstructured":"Sainz RM, Rodriguez-Quintero JH, Maldifassi MC, Stiles BM, Wennerberg E (2023) Tumour immune escape via P2X7 receptor signalling. Front Immunol 14:1287310. https:\/\/doi.org\/10.3389\/fimmu.2023.1287310","journal-title":"Front Immunol"},{"key":"10108_CR54","doi-asserted-by":"publisher","unstructured":"Whiteley AE, Price TT, Cantelli G, Sipkins DA (2021) Leukaemia: a model metastatic disease. Nat Rev Cancer 21(7):461\u2013475. https:\/\/doi.org\/10.1038\/s41568-021-00355-z","DOI":"10.1038\/s41568-021-00355-z"},{"key":"10108_CR55","doi-asserted-by":"publisher","unstructured":"Sluyter R, Barden JA, Wiley JS (2001) Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 304(2):231\u2013236. https:\/\/doi.org\/10.1007\/s004410100372","DOI":"10.1007\/s004410100372"},{"issue":"15","key":"10108_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158174","volume":"23","author":"SKF De Salis","year":"2022","unstructured":"De Salis SKF, Li L, Chen Z, Lam KW, Skarratt KK, Balle T,\u00a0Fuller SJ (2022) Alternatively spliced isoforms of the P2X7 receptor: structure, function and disease associations. Int J Mol Sci 23(15):8174. https:\/\/doi.org\/10.3390\/ijms23158174","journal-title":"Int J Mol Sci"},{"key":"10108_CR57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11302-012-9320-9","volume":"84","author":"S Gadeock","year":"2012","unstructured":"Gadeock S, Pupovac A, Sluyter V, Spildrejorde M, Sluyter R (2012) P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells. Purinergic Signal 8(4):669\u2013676. https:\/\/doi.org\/10.1007\/s11302-012-9320-9","journal-title":"Purinergic Signal"},{"issue":"10","key":"10108_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03058-9","volume":"11","author":"A Pegoraro","year":"2020","unstructured":"Pegoraro A, Orioli E, De Marchi E, Salvestrini V, Milani A, Di Virgilio F et al (2020) Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression. Cell Death Dis 11(10):876. https:\/\/doi.org\/10.1038\/s41419-020-03058-9","journal-title":"Cell Death Dis"},{"key":"10108_CR59","unstructured":"Nie K, Zheng GG, Lin YM, Zhang XJ, Wang L, Song YH et al (2006) [Cloning and functional analysis of P2X7 receptor from J6-1 leukemia cells]. Zhonghua xueyexue zazhi 27(9):602\u2013605"},{"issue":"11","key":"10108_CR60","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0145-2126(94)90165-1","volume":"18","author":"K Wu","year":"1994","unstructured":"Wu KF, Rao Q, Zheng GG, Geng YQ, Li M, Kong J et al (1994) Enhancement of J6\u20131 human leukemic cell proliferation by cell-cell contact: role of an M-CSF-like membrane-associated growth factor MAF-J6-1. Leuk Res 18(11):843\u2013849. https:\/\/doi.org\/10.1016\/0145-2126(94)90165-1","journal-title":"Leukemia Res"},{"issue":"1","key":"10108_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/srep26280","volume":"6","author":"E Salaro","year":"2016","unstructured":"Salaro E, Rambaldi A, Falzoni S, Amoroso FS, Franceschini A, Sarti AC et al (2016) Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Sci Rep 6:26280. https:\/\/doi.org\/10.1038\/srep26280","journal-title":"Sci Rep"},{"issue":"1","key":"10108_CR62","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bbrc.2009.11.087","volume":"391","author":"JH Chong","year":"2010","unstructured":"Chong JH, Zheng GG, Zhu XF, Guo Y, Wang L, Ma CH et al (2010) Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias. Biochem Biophys Res Commun 391(1):498\u2013504. https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.087","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10108_CR63","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.V99.2.706","volume":"99","author":"E Adinolfi","year":"2002","unstructured":"Adinolfi E, Melchiorri L, Falzoni S, Chiozzi P, Morelli A, Tieghi A et al (2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99(2):706\u2013708. https:\/\/doi.org\/10.1182\/blood.V99.2.706","journal-title":"Blood"},{"issue":"9349","key":"10108_CR64","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/s0140-6736(02)11933-7","volume":"360","author":"F Di Virgilio","year":"2002","unstructured":"Di Virgilio F, Wiley JS (2002) The P2X7 receptor of CLL lymphocytes-a molecule with a split personality. Lancet 360(9349):1898\u20131899. https:\/\/doi.org\/10.1016\/s0140-6736(02)11933-7","journal-title":"Lancet"},{"key":"10108_CR65","doi-asserted-by":"publisher","unstructured":"Chen SY, Feng WL, Yang X, Liao JF, Wang LN, Lin YM et al (2014) [Expression of P2X family receptors in peritoneal macrophages of mouse with acute T lymphoblastic leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22(3):623\u2013628. https:\/\/doi.org\/10.7534\/j.issn.1009-2137.2014.03.009","DOI":"10.7534\/j.issn.1009-2137.2014.03.009"},{"key":"10108_CR66","doi-asserted-by":"publisher","unstructured":"Chen S, Feng W, Yang X, Yang W, Ru Y, Liao J et al (2014) Functional expression of P2X family receptors in macrophages is affected by microenvironment in mouse T cell acute lymphoblastic leukemia. Biochem Biophys Res Commun 446(4):1002\u20131009. https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.048","DOI":"10.1016\/j.bbrc.2014.03.048"},{"key":"10108_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12015-016-9651-y","volume":"123","author":"W Feng","year":"2016","unstructured":"Feng W, Yang F, Wang R, Yang X, Wang L, Chen C et al (2016) High level P2X7-mediated signaling impairs function of hematopoietic stem\/progenitor cells. Stem Cell Rev Rep 12(3):305\u2013314. https:\/\/doi.org\/10.1007\/s12015-016-9651-y","journal-title":"Stem Cell Rev Rep"},{"key":"10108_CR68","doi-asserted-by":"publisher","first-page":"C1189","DOI":"10.1152\/ajpcell.2000.279.4.C1189","volume":"2794","author":"BJ Gu","year":"2000","unstructured":"Gu BJ, Zhang WY, Bendall LJ, Chessell IP, Buell GN, Wiley JS (2000) Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors. Am J Physiol Cell Physiol 279(4):C1189\u2013C1197. https:\/\/doi.org\/10.1152\/ajpcell.2000.279.4.C1189","journal-title":"Am J Physiol Cell Physiol"},{"key":"10108_CR69","doi-asserted-by":"publisher","first-page":"102002","DOI":"10.1016\/j.jbc.2022.102002","volume":"2986","author":"XF Ma","year":"2022","unstructured":"Ma XF, Wang TT, Wang WH, Guan L, Guo CR, Li XH et al (2022) The long \u03b22,3-sheets encoded by redundant sequences play an integral role in the channel function of P2X7 receptors. J Biol Chem 298(6):102002. https:\/\/doi.org\/10.1016\/j.jbc.2022.102002","journal-title":"J Biol Chem"},{"key":"10108_CR70","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41375-021-01352-9","volume":"361","author":"M Adamiak","year":"2021","unstructured":"Adamiak M, Bujko K, Thapa A, Pensato V, Brzezniakiewicz-Janus K, Ratajczak J et al (2022) The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem\/progenitor cell mobilization and homing\u2014a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking. Leukemia 36(1):248\u2013256. https:\/\/doi.org\/10.1038\/s41375-021-01352-9","journal-title":"Leukemia"},{"key":"10108_CR71","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3324\/haematol.2019.243360","volume":"1065","author":"F Wenli","year":"2020","unstructured":"Feng W, Yang X, Wang L, et al (2021) P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3. Haematologica 106(5):1278\u20131289. https:\/\/doi.org\/10.3324\/haematol.2019.243360","journal-title":"Haematologica"},{"key":"10108_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.exphem.2021.10.001","volume":"104","author":"X He","year":"2021","unstructured":"He X, Zhang Y, Xu Y, Xie L, Yu Z, Zheng J (2021) Function of the P2X7 receptor in hematopoiesis and leukemogenesis. Exp Hematol 104:40\u201347. https:\/\/doi.org\/10.1016\/j.exphem.2021.10.001","journal-title":"Exp Hematol"},{"key":"10108_CR73","doi-asserted-by":"publisher","first-page":"e140242","DOI":"10.1172\/jci140242","volume":"1314","author":"X He","year":"2021","unstructured":"He X, Wan J, Yang X, Zhang X, Huang D, Li X et al (2021) Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models. J Clin Invest 131(4):e140242. https:\/\/doi.org\/10.1172\/jci140242","journal-title":"J Clin Invest"},{"key":"10108_CR74","doi-asserted-by":"publisher","unstructured":"Salvestrini V, Orecchioni S, Talarico G, Reggiani F, Mazzetti C, Bertolini F et al (2017) Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells. Oncotarget 8(4):5895\u20135908. https:\/\/doi.org\/10.18632\/oncotarget.13927","DOI":"10.18632\/oncotarget.13927"},{"key":"10108_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biochi.2017.02.001","volume":"135","author":"R Shakeri","year":"2017","unstructured":"Shakeri R, Kheirollahi A, Davoodi J (2017) Apaf-1: regulation and function in cell death. Biochimie 135:111\u2013125. https:\/\/doi.org\/10.1016\/j.biochi.2017.02.001","journal-title":"Biochimie"},{"key":"10108_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.diff.2022.10.001","volume":"128","author":"ZN MohdYasin","year":"2022","unstructured":"Mohd Yasin ZN, Mohd Idrus FN, Hoe CH, Yvonne-Tee GB (2022) Macrophage polarization in THP-1 cell line and primary monocytes: a systematic review. Differentiation 128:67\u201382. https:\/\/doi.org\/10.1016\/j.diff.2022.10.001","journal-title":"Differentiation"},{"key":"10108_CR77","doi-asserted-by":"publisher","first-page":"e67134","DOI":"10.1371\/journal.pone.0067134","volume":"86","author":"W Tse","year":"2013","unstructured":"Glass C, Wuertzer C, Cui X, Bi Y, Davuluri R et al (2013) Global identification of EVI1 target genes in acute myeloid leukemia. PLoS One 8(6):e67134. https:\/\/doi.org\/10.1371\/journal.pone.0067134","journal-title":"PLoS ONE"},{"key":"10108_CR78","doi-asserted-by":"publisher","unstructured":"Garcia-Cuellar MP, Steger J, F\u00fcller E, Hetzner K, Slany RK (2015) Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia. Haematologica 100(7):905\u2013913. https:\/\/doi.org\/10.3324\/haematol.2015.124032","DOI":"10.3324\/haematol.2015.124032"},{"key":"10108_CR79","doi-asserted-by":"publisher","unstructured":"Thorne RM, Milne TA (2015) Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia. Haematologica 100(7):850\u2013853. https:\/\/doi.org\/10.3324\/haematol.2015.129932","DOI":"10.3324\/haematol.2015.129932"},{"issue":"1","key":"10108_CR80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4049\/jimmunol.175.1.82","volume":"175","author":"G Cabrini","year":"2005","unstructured":"Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P et al (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 175(1):82\u201389. https:\/\/doi.org\/10.4049\/jimmunol.175.1.82","journal-title":"J Immunol"},{"key":"10108_CR81","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11302-009-9168-9","volume":"61","author":"C Sun","year":"2009","unstructured":"Sun C, Chu J, Singh S, Salter RD (2010) Identification and characterization of a novel variant of the human P2X7 receptor resulting in gain of function. Purinergic Signal 6(1):31\u201345. https:\/\/doi.org\/10.1007\/s11302-009-9168-9","journal-title":"Purinergic Signal"},{"issue":"19","key":"10108_CR82","doi-asserted-by":"publisher","first-page":"17108","DOI":"10.1074\/jbc.M212759200","volume":"278","author":"JS Wiley","year":"2003","unstructured":"Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ, Smart ML et al (2003) An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 278(19):17108\u201317113. https:\/\/doi.org\/10.1074\/jbc.M212759200","journal-title":"J Biol Chem"},{"key":"10108_CR83","doi-asserted-by":"publisher","unstructured":"Koldej R, Collins J, Ritchie D (2018) P2X7 polymorphisms and stem cell mobilisation. Leukemia 32(12):2724\u20132726. https:\/\/doi.org\/10.1038\/s41375-018-0232-8","DOI":"10.1038\/s41375-018-0232-8"},{"key":"10108_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08156-4","author":"JS Wiley","year":"2002","unstructured":"Wiley JS, Dao-Ung LP, Gu BJ, Sluyter R, Shemon AN, Li C et al (2002) A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet\u00a0359(9312):1114\u20131119.\u00a0https:\/\/doi.org\/10.1016\/s0140-6736(02)08156-4","journal-title":"Lancet"},{"key":"10108_CR85","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/s0140-6736(02)11917-9","volume":"3609349","author":"U Thunberg","year":"2002","unstructured":"Thunberg U, Tobin G, Johnson A, S\u00f6derberg O, Padyukov L, Hultdin M et al (2002) Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet\u00a0360(9349):1935\u20131939.\u00a0https:\/\/doi.org\/10.1016\/s0140-6736(02)11917-9","journal-title":"Lancet"},{"key":"10108_CR86","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1046\/j.1365-2141.2003.04563.x","volume":"1231","author":"J Starczynski","year":"2003","unstructured":"Starczynski J, Pepper C, Pratt G, Hooper L, Thomas A, Hoy T et al (2003) The P2X7 receptor gene polymorphism 1513 A\u2013>C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. Br J Haematol 123(1):66\u201371. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04563.x","journal-title":"British J Haematol"},{"key":"10108_CR87","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11302-020-09737-8","volume":"164","author":"W-J Zhang","year":"2020","unstructured":"Zhang WJ, Zhu ZM (2020) Association between the rs3751143 polymorphism of P2RX7 gene and chronic lymphocytic leukemia: A meta-analysis. Purinergic Signal 16(4):479\u2013484. https:\/\/doi.org\/10.1007\/s11302-020-09737-8","journal-title":"Purinergic Signal"},{"key":"10108_CR88","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3322\/canjclin.44.6.326","volume":"446","author":"SM Devine","year":"1994","unstructured":"Devine SM, Larson RA (1994) Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin 44(6):326\u2013352. https:\/\/doi.org\/10.3322\/canjclin.44.6.326","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10108_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123089","volume":"10","author":"RJ Soares-Bezerra","year":"2015","unstructured":"Soares-Bezerra RJ, Ferreira NC, Alberto AV, Bonavita AG, Fidalgo-Neto AA, Calheiros AS et al (2015) An improved method for P2X7R antagonist screening. PLoS One 10(5):e0123089. https:\/\/doi.org\/10.1371\/journal.pone.0123089","journal-title":"PLoS One"},{"key":"10108_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11302-019-09684-z","volume":"161","author":"KJ Filippin","year":"2019","unstructured":"Filippin KJ, de Souza KFS, de Araujo J\u00fanior RT et al (2020) Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets. Purinergic Signal 16(1):1\u201315. https:\/\/doi.org\/10.1007\/s11302-019-09684-z","journal-title":"Purinergic Signal"},{"key":"10108_CR91","doi-asserted-by":"publisher","unstructured":"De Marchi E, Pegoraro A, Adinolfi E (2022) Administration of P2X7 receptor blockers in oncological experimental models. Methods Mol Biol 2510:303\u2013314. https:\/\/doi.org\/10.1007\/978-1-0716-2384-8_17","DOI":"10.1007\/978-1-0716-2384-8_17"},{"key":"10108_CR92","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11302-021-09776-9","volume":"172","author":"M Drill","year":"2021","unstructured":"Drill M, Jones NC, Hunn M, O\u2019Brien TJ, Monif M (2021) Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer. Purinergic Signal 17(2):215\u2013227. https:\/\/doi.org\/10.1007\/s11302-021-09776-9","journal-title":"Purinergic Signal"},{"key":"10108_CR93","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3389\/fimmu.2017.01918","volume":"8","author":"M Lecciso","year":"2017","unstructured":"Lecciso M, Ocadlikova D, Sangaletti S, Trabanelli S, De Marchi E, Orioli E et al (2017) ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells. Front Immunol 8:1918. https:\/\/doi.org\/10.3389\/fimmu.2017.01918","journal-title":"Front Immunol"},{"issue":"3","key":"10108_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031775","volume":"25","author":"P Cuthbertson","year":"2024","unstructured":"Cuthbertson P, Button A, Sligar C et al (2024) Post-transplant cyclophosphamide combined with brilliant blue G reduces graft-versus-host disease without compromising graft-versus-leukaemia immunity in humanised mice. Int J Mol Sci 25(3):1775. https:\/\/doi.org\/10.3390\/ijms25031775","journal-title":"Int J Mol Sci"},{"key":"10108_CR95","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11302-016-9510-y","volume":"123","author":"C Ledderose","year":"2016","unstructured":"Ledderose C, Woehrle T, Ledderose S, Strasser K, Seist R, Bao Y,\u00a0Zhang J, Junger WG (2016) Cutting off the power: inhibition of leukemia cell growth by pausing basal ATP release and P2X receptor signaling? Purinergic Signal 12(3):439\u2013451. https:\/\/doi.org\/10.1007\/s11302-016-9510-y","journal-title":"Purinergic Signal"},{"key":"10108_CR96","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.2910190505","volume":"195","author":"U Schneider","year":"1977","unstructured":"Schneider U, Schwenk HU, Bornkamm G (1977) Characterization of EBV-genome negative \u201cnull\u201d and \u201cT\u201d cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19(5):621\u2013626. https:\/\/doi.org\/10.1002\/ijc.2910190505","journal-title":"Int J Cancer"},{"key":"10108_CR97","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/toxins11090489","volume":"119","author":"BA Vega","year":"2019","unstructured":"Vega BA, Belinka BA Jr, Kachlany SC (2019) Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera\u00ae): mechanisms of action and therapeutic applications.\u00a0Toxins (Basel) 11(9):489. https:\/\/doi.org\/10.3390\/toxins11090489","journal-title":"Toxins"},{"issue":"1","key":"10108_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97545-4","volume":"11","author":"DJ Prince","year":"2021","unstructured":"Prince DJ, Patel D, Kachlany SC (2021) Leukotoxin (LtxA\/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes. Sci Rep 11(1):18086. https:\/\/doi.org\/10.1038\/s41598-021-97545-4","journal-title":"Sci Rep"},{"key":"10108_CR99","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000331731","volume":"282","author":"W Wang","year":"2011","unstructured":"Wang W, Xiao J, Adachi M, Liu Z, Zhou J (2011) 4-aminopyridine induces apoptosis of human acute myeloid leukemia cells via increasing [Ca2+]i through P2X7 receptor pathway. Cellular Physiol Biochem 28(2):199\u2013208. https:\/\/doi.org\/10.1159\/000331731","journal-title":"Cellular Physiol Biochem: Int J Exp Cell Physiol, Biochem, Pharmacol"},{"key":"10108_CR100","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/nu16030383","volume":"163","author":"DA Pires","year":"2024","unstructured":"Pires DA, Brand\u00e3o-Rangel MAR, Silva-Reis A, Ol\u00edmpio FRS, Aimbire F, Oliveira CR et al (2024) Vitamin C inhibits lipopolysaccharide-induced hyperinflammatory state of chronic myeloid leukemia cells through purinergic signaling and autophagy. Nutrients 16(3):383. https:\/\/doi.org\/10.3390\/nu16030383","journal-title":"Nutrients"},{"key":"10108_CR101","doi-asserted-by":"publisher","unstructured":"Ferrari D, Pizzirani C, Adinolfi E, Forchap S, Sitta B, Turchet L et al (2004) The antibiotic polymyxin B modulates P2X7 receptor function. J Immunol 173(7):4652\u20134660. https:\/\/doi.org\/10.4049\/jimmunol.173.7.4652","DOI":"10.4049\/jimmunol.173.7.4652"},{"key":"10108_CR102","doi-asserted-by":"publisher","first-page":"114263","DOI":"10.1016\/j.biopha.2023.114263","volume":"159","author":"YF Bella","year":"2023","unstructured":"Bella YF, Oliveira CR, Mateus-Silva JR et al (2023) A phytotherapic blend immunity-6\u2122 inhibits myeloid leukemic cells 2 activation involving purinergic signaling. Biomed Pharmacother 159:114263. https:\/\/doi.org\/10.1016\/j.biopha.2023.114263","journal-title":"Biomed Pharmacother"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-025-10108-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:52:30Z","timestamp":1766447550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-025-10108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10108"],"URL":"https:\/\/doi.org\/10.1007\/s11302-025-10108-4","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}